NanoMab is a privately held biopharmaceutical company focusing on cancer precision therapies via the development of next generation radiopharmaceuticals.
We are developing medicine for fast and specific delivery of radiation to treat cancer. A therapeutic product is made by a camelid antibody labelled with a radioisotope of therapeutic radiation.